SRSF3 is a multiple cancer related splicing factor, namely glioblastoma [44], colon cancer [45], oral squamous carcinoma [46], etc. Moreover, the expression of SRSF2/3 is significantly decreased in de novo AML patients in comparison with that of healthy controls. Here, SLU7 is linked to glioblastoma.